T Cell-Independent and Toll-like Receptor-Dependent Antigen-Driven Activation of Autoreactive B Cells

Immunity

Volumn 29, Issue 2, 2008, Pages 249-260

  Herlands, Robin A ^a   Christensen, Sean R ^a   Sweet, Rebecca A ^a   Hershberg, Uri ^a   Shlomchik, Mark J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CELLIMMUNO; MOLIMMUNO

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; LIGAND; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; CELL STIMULATION; CHROMATIN; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CHROMATIN; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED MRL LPR; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 48749085121     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2008.06.009     Document Type: Article

References (54)

1. Adams S., Leblanc P., and Datta S.K. Junctional region sequences of T-cell receptor beta-chain genes expressed by pathogenic anti-DNA autoantibody-inducing helper T cells from lupus mice: possible selection by cationic autoantigens. Proc. Natl. Acad. Sci. USA 88 (1991) 11271-11275
2. Ando D.G., Sercarz E.E., and Hahn B.H. Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. J. Immunol. 138 (1987) 3185-3190
3. Browning J.L. B cells move to centre stage: novel opportunities for autoimmune disease treatment. Nat. Rev. Drug Discov. 5 (2006) 564-576
4. Carteron N.L., Schimenti C.L., and Wofsy D. Treatment of murine lupus with F(ab')2 fragments of monoclonal antibody to L3T4. Suppression of autoimmunity does not depend on T helper cell depletion. J. Immunol. 142 (1989) 1470-1475
5. Christensen S.R., Kashgarian M., Alexopoulou L., Flavell R.A., Akira S., and Shlomchik M.J. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202 (2005) 321-331
6. Christensen S.R., Shupe J., Nickerson K., Kashgarian M., Flavell R.A., and Shlomchik M.J. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25 (2006) 417-428
7. Connolly K., Roubinian J.R., and Wofsy D. Development of murine lupus in CD4-depleted NZB/NZW mice. Sustained inhibition of residual CD4+ T cells is required to suppress autoimmunity. J. Immunol. 149 (1992) 3083-3088
8. Culton D.A., O'Conner B.P., Conway K.L., Diz R., Rutan J., Vilen B.J., and Clarke S.H. Early preplasma cells define a tolerance checkpoint for autoreactive B cells. J. Immunol. 176 (2006) 790-802
9. Fields M.L., Hondowicz B.D., Metzgar M.H., Nish S.A., Wharton G.N., Picca C.C., Caton A.J., and Erikson J. CD4+ CD25+ regulatory T cells inhibit the maturation but not the initiation of an autoantibody response. J. Immunol. 175 (2005) 4255-4264
10. Fields M.L., Nish S.A., Hondowicz B.D., Metzgar M.H., Wharton G.N., Caton A.J., and Erikson J. The influence of effector T cells and Fas ligand on lupus-associated B cells. J. Immunol. 175 (2005) 104-111
11. Gavin A.L., Hoebe K., Duong B., Ota T., Martin C., Beutler B., and Nemazee D. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314 (2006) 1936-1938
12. Good K.L., Bryant V.L., and Tangye S.G. Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J. Immunol. 177 (2006) 5236-5247
13. Hannum L.G., Haberman A.M., Anderson S.M., and Shlomchik M.J. Germinal center initiation, variable gene region hypermutation, and mutant B cell selection without detectable immune complexes on follicular dendritic cells. J. Exp. Med. 192 (2000) 931-942
14. Hannum L.G., Ni D., Haberman A.M., Weigert M.G., and Shlomchik M.J. A disease-related RF autoantibody is not tolerized in a normal mouse: implications for the origins of autoantibodies in autoimmune disease. J. Exp. Med. 184 (1996) 1269-1278
15. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., and Bauer S. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8. Science 303 (2004) 1526-1529
16. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
17. Herlands R.A., William J., Hershberg U., and Shlomchik M.J. Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites. Eur. J. Immunol. 37 (2007) 3339-3351
18. Hiromatsu K. A protective role of gamma/delta T cells in primary infection with Listeria monocytogenes in mice. J. Exp. Med. 175 (1992) 49-56
19. Houlden B.A. A TCR gamma delta cell recognizing a novel TL-encoded gene product. Cold Spring Harb. Symp. Quant. Biol. 54 (1989) 45-55
20. Jacobson B.A., Panka D.J., Nguyen K.A., Erikson J., Abbas A.K., and Marshak-Rothstein A. Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity 3 (1995) 509-519
21. Kawai T., Adachi O., Ogawa T., Takeda K., and Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11 (1999) 115-122
22. Kleinstein S.H., Louzoun Y., and Shlomchik M.J. Estimating hypermutation rates from clonal tree data. J. Immunol. 171 (2003) 4639-4649
23. Lau C.M., Broughton C., Tabor A.S., Akira S., Flavell R.A., Mamula M.J., Christensen S.R., Shlomchik M.J., Viglianti G.A., Rifkin I.R., and Marshak-Rothstein A. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202 (2005) 1171-1177
24. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., and Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 (2002) 603-607
25. Lin R.-H., Mamula M.J., Hardin J.A., and Janeway Jr. C.A. Induction of autoreactive B cells allows priming of autoreactive T cells. J. Exp. Med. 173 (1991) 1433-1439
26. Losman M.J., Fasy T.M., Novick K.E., and Monestier M. Monoclonal autoantibodies to subnucleosomes from a MRL/Mp-+/+ mouse: oligoclonality of the antibody response and recognition of a determinant composed for histones H2A, H2B, and DNA. J. Immunol. 148 (1992) 1561-1569
27. Losman M.J., Fasy T.M., Novick K.E., and Monestier M. Relationships among antinuclear antibodies from autoimmune MRL mice reacting with histone H2A-H2B dimers and DNA. Int. Immunol. 5 (1993) 513-523
28. Lund J.M., Alexopoulou L., Sato A., Karow M., Adams N.C., Gale N.W., Iwasaki A., and Flavell R.A. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101 (2004) 5598-5603
29. MacLennan I.C.M., Toellner K.-M., Cunningham A.F., Serre K., Sze D.M.Y., Zuniga E., Cook M.C., and Vinuesa C.G. Extrafollicular antibody responses. Immunol. Rev. 194 (2003) 8-18
30. Mamula M.J., Fatenejad S., and Craft J. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J. Immunol. 152 (1994) 1453-1461
31. Mandik-Nayak L., Seo S.J., Sokol C., Potts K.M., Bui A., and Erikson J. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Exp. Med. 189 (1999) 1799-1814
32. Meyer-Bahlburg A., Khim S., and Rawlings D.J. B cell intrinsic TLR signals amplify but are not required for humoral immunity. J. Exp. Med. 204 (2007) 3095-3101
33. Pasare C., and Medzhitov R. Control of B-cell responses by Toll-like receptors. Nature 438 (2005) 364-368
34. Peng S.L. Pathogenesis of autoimmunity in alphabeta T cell-deficient lupus-prone mice. Clin. Exp. Immunol. 111 (1998) 107-116
35. Peng S.L., Madaio M.P., Hayday A.C., and Craft J. Propagation and regulation of systemic autoimmunity by gammadelta T cells. J. Immunol. 157 (1996) 5689-5698
36. Peng S.L., Madaio M.P., Hughes D.P., Crispe I.N., Owen M.J., Wen L., Hayday A.C., and Craft J. Murine lupus in the absence of alpha beta T cells. J. Immunol. 156 (1996) 4041-4049
37. Rossbacher J., and Shlomchik M.J. The B cell receptor itself can activate complement to provide the complement receptor 1/2 ligand required to enhance B cell immune responses in vivo. J. Exp. Med. 198 (2003) 591-602
38. Sadanaga A., Nakashima H., Akahoshi M., Masutani K., Miyake K., Igawa T., Sugiyama N., Niiro H., and Harada M. Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Arthritis Rheum. 56 (2007) 1618-1628
39. Seo S.J., Fields M.L., Buckler J.L., Reed A.J., Mandik-Nayak L., Nish S.A., Noelle R.J., Turka L.A., Finkelman F.D., Caton A.J., and Erikson J. The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity 16 (2002) 535-546
40. Shlomchik M.J., Craft J.E., and Mamula M.J. From T to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 1 (2001) 147-153
41. Shlomchik M.J., Zharhary D., Saunders T., Camper S., and Weigert M. A Rheumatoid factor transgenic mouse model of autoantibody regulation. Int. Immunol. 5 (1993) 1329-1341
42. Singh R.R., and Hahn B.H. Reciprocal T-B determinant spreading develops spontaneously in murine lupus: implications for pathogenesis. Immunol. Rev. 164 (1998) 201-208
43. Tan E.M. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44 (1989) 93-151
44. Tarlinton D. B-cell memory: are subsets necessary?. Nat. Rev. Immunol. 6 (2006) 785-790
45. Viglianti G.A., Lau C.M., Hanley T.M., Miko B.A., Shlomchik M.J., and Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 19 (2003) 837-847
46. Wang H., and Shlomchik M.J. Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice. J. Exp. Med. 190 (1999) 639-649
47. Weisel F., Wellmann U., and Winkler T.H. Autoreactive B cells get activated in extrafollicular sites. Eur. J. Immunol. 37 (2007) 3330-3333
48. William J., Euler C., Christensen S., and Shlomchik M.J. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297 (2002) 2066-2070
49. William J., Euler C., Leadbetter E., Marshak-Rothstein A., and Shlomchik M.J. Visualizing the onset and evolution of an autoantibody response in systemic autoimmunity. J. Immunol. 174 (2005) 6872-6878
50. William J., Euler C., Primarolo N., and Shlomchik M.J. B cell tolerance checkpoints that restrict pathways of antigen-driven differentiation. J. Immunol. 176 (2006) 2142-2151
51. William J., Euler C., and Shlomchik M.J. Short-lived plasmablasts dominate the early spontaneous rheumatoid factor response: differentiation pathways, hypermutating cell types, and affinity maturation outside the germinal center. J. Immunol. 174 (2005) 6879-6887
52. Wofsy D. Treatment of murine lupus with anti-CD4 monoclonal antibodies. Immunol. Ser. 59 (1993) 221-236
53. Wofsy D., and Seaman W.E. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. J. Immunol. 138 (1987) 3247-3253
54. Zelenika D., Adams E., Humm S., Lin C.Y., Waldmann H., and Cobbold S.P. The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance. Immunol. Rev. 182 (2001) 164-179